Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Newbury Street Acquisition Unit | NBSTU | Nov 26, 2024 | 10.87 | 0.00 |
Newbury Street II Acquisition Unit | NTWOU | Nov 26, 2024 | 9.96 | 0.00 |
Newegg Commerce | NEGG | Nov 26, 2024 | 0.60 | -1.02 |
Newell Brands | NWL | Nov 26, 2024 | 9.34 | -2.91 |
NewGenIvf Group | NIVF | Nov 26, 2024 | 0.37 | -11.06 |
NewJersey Resources | NJR | Nov 26, 2024 | 50.71 | -1.53 |
Newmark Group A | NMRK | Nov 26, 2024 | 15.63 | +0.71 |
NewMarket | NEU | Nov 26, 2024 | 542.75 | -0.30 |
Newmont | NEM | Nov 26, 2024 | 42.25 | -0.49 |
Newpark Resources | NR | Nov 26, 2024 | 8.17 | +1.36 |
News A | NWSA | Nov 26, 2024 | 29.28 | -0.61 |
News B | NWS | Nov 26, 2024 | 32.01 | -0.34 |
NewtekOne | NEWT | Nov 26, 2024 | 14.37 | -2.64 |
Nexa Resources | NEXA | Nov 26, 2024 | 7.65 | +1.32 |
Nexalin Technology | NXL | Nov 26, 2024 | 3.85 | -1.28 |
NexGel | NXGL | Nov 26, 2024 | 3.23 | -4.15 |
NexGen | NXE | Nov 26, 2024 | 8.31 | -0.95 |
NexImmune | NEXI | Nov 26, 2024 | 2.31 | 0.00 |
NexPoint Diversified Real Estate Trust Pref | NXDT-A | Nov 26, 2024 | 16.16 | -0.65 |
Nexpoint Diversified REIT | NXDT | Nov 26, 2024 | 5.51 | +2.04 |
Nexpoint Real Estate Finance | NREF | Nov 26, 2024 | 17.26 | +0.82 |
NexPoint Real Estate Finance A | NREF-A | Nov 26, 2024 | 23.77 | +0.46 |
Nexpoint Residential Trust | NXRT | Nov 26, 2024 | 47.74 | +1.23 |
Nexstar Media Group A | NXST | Nov 26, 2024 | 170.29 | -0.19 |
Next Technology | NXTT | Nov 26, 2024 | 2.05 | -9.69 |
NextCure | NXTC | Nov 26, 2024 | 1.17 | -2.50 |
NextDecade | NEXT | Nov 26, 2024 | 7.18 | -2.58 |
Nextdoor | KIND | Nov 26, 2024 | 2.47 | -2.37 |
NextEra Energy | NEE | Nov 26, 2024 | 77.49 | +1.11 |
Nextera Energy Partners LP U | NEP | Nov 26, 2024 | 17.19 | -0.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.